drugset / Trial / NCT03723811

Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.

NCT03723811 ↗

Phase 2 Completed 152 enrolled Samjin Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is to evaluate the efficacy and safety of SJP002 ophthalmic solution compared to placebo in patients with Dry Eye Syndrome.

Timeline

Start
2017-11-28
Primary completion
2018-06-26
Completion
2018-06-26

Drugs

EvaluationDrugModalityDoseRoute
Subject SJP002 Unknown 1 unknown Other

Indications